Antoinette Wozniak, MD, FACP, FASCO, discusses optimizing the use of immunotherapy in patients with non–small cell lung cancer.
Antoinette Wozniak, MD, FACP, FASCO
Advertisement
Articles by Antoinette Wozniak, MD, FACP, FASCO
Antoinette Wozniak, MD, FACP, FASCO, discusses sequencing with immunotherapy and chemoradiation in select patients with stage III lung cancer.
Advertisement
Latest Updated Articles
Dr. Wozniak on Optimizing the Use of Immunotherapy in NSCLCMarch 30th 2021
Dr. Wozniak on Sequencing Immunotherapy in Lung CancerNovember 4th 2019
Advertisement
Advertisement
Trending on OncLive
1
Frontline Sac-TMT Plus Pembrolizumab Meets PFS End Point in PD-L1–Negative, Nonsquamous NSCLC
2
Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer
3
Dr Cerchione on the FDA Approval of Subcutaneous Isatuximab in Myeloma
4
CAR T-Cell Engineering Produces Early Efficacy Signals in Glioblastoma
5